181 related articles for article (PubMed ID: 36798517)
1. Systemic CD4 cytotoxic T cells improve protection against PRRSV-1 transplacental infection.
Li Y; Díaz I; Martín-Valls G; Beyersdorf N; Mateu E
Front Immunol; 2022; 13():1020227. PubMed ID: 36798517
[TBL] [Abstract][Full Text] [Related]
2. Recombinant Porcine Reproductive and Respiratory Syndrome Virus Expressing Membrane-Bound Interleukin-15 as an Immunomodulatory Adjuvant Enhances NK and γδ T Cell Responses and Confers Heterologous Protection.
Cao QM; Ni YY; Cao D; Tian D; Yugo DM; Heffron CL; Overend C; Subramaniam S; Rogers AJ; Catanzaro N; LeRoith T; Roberts PC; Meng XJ
J Virol; 2018 Jul; 92(13):. PubMed ID: 29643245
[TBL] [Abstract][Full Text] [Related]
3. Antibody response and maternal immunity upon boosting PRRSV-immune sows with experimental farm-specific and commercial PRRSV vaccines.
Geldhof MF; Van Breedam W; De Jong E; Lopez Rodriguez A; Karniychuk UU; Vanhee M; Van Doorsselaere J; Maes D; Nauwynck HJ
Vet Microbiol; 2013 Dec; 167(3-4):260-71. PubMed ID: 24041768
[TBL] [Abstract][Full Text] [Related]
4. Levels of neutralizing antibodies against resident farm strain or vaccine strain are not indicators of protection against PRRSV-1 vertical transmission under farm conditions.
Martin-Valls GE; Li Y; Clilverd H; Soto J; Cortey M; Mateu E
BMC Vet Res; 2023 Oct; 19(1):217. PubMed ID: 37858141
[TBL] [Abstract][Full Text] [Related]
5. An engineered anti-idiotypic antibody-derived killer peptide (KP) early activates swine inflammatory monocytes, CD3
Ferrari L; Martelli P; Saleri R; De Angelis E; Ferrarini G; Cavalli V; Passeri B; Bazzoli G; Ogno G; Magliani W; Borghetti P
Comp Immunol Microbiol Infect Dis; 2020 Oct; 72():101523. PubMed ID: 32758800
[TBL] [Abstract][Full Text] [Related]
6. Influence of PRRSV-1 vaccination and infection on mononuclear immune cells at the maternal-fetal interface.
Stas MR; Kreutzmann H; Stadler J; Sassu EL; Mair KH; Koch M; Knecht C; Stadler M; Dolezal M; Balka G; Zaruba M; Mötz M; Saalmüller A; Rümenapf T; Gerner W; Ladinig A
Front Immunol; 2022; 13():1055048. PubMed ID: 36426366
[TBL] [Abstract][Full Text] [Related]
7. A highly pathogenic porcine reproductive and respiratory syndrome virus type 1 (PRRSV-1) strongly modulates cellular innate and adaptive immune subsets upon experimental infection.
Ferrari L; Canelli E; De Angelis E; Catella A; Ferrarini G; Ogno G; Bonati L; Nardini R; Borghetti P; Martelli P
Vet Microbiol; 2018 Mar; 216():85-92. PubMed ID: 29519531
[TBL] [Abstract][Full Text] [Related]
8. Lymphocyte activation as cytokine gene expression and secretion is related to the porcine reproductive and respiratory syndrome virus (PRRSV) isolate after in vitro homologous and heterologous recall of peripheral blood mononuclear cells (PBMC) from pigs vaccinated and exposed to natural infection.
Ferrari L; Martelli P; Saleri R; De Angelis E; Cavalli V; Bresaola M; Benetti M; Borghetti P
Vet Immunol Immunopathol; 2013 Feb; 151(3-4):193-206. PubMed ID: 23228653
[TBL] [Abstract][Full Text] [Related]
9. Effects of a water-soluble formulation of tylvalosin on disease caused by porcine reproductive and respiratory syndrome virus alone in sows or in combination with Mycoplasma hyopneumoniae in piglets.
Rodriguez AL; Fowler VL; Huether M; Reddick D; Tait-Burkard C; O'Shea M; Perkins S; Dias N; Buterbaugh R; Benchaoui HA
BMC Vet Res; 2023 Feb; 19(1):31. PubMed ID: 36726139
[TBL] [Abstract][Full Text] [Related]
10. Impact of immunizations with porcine reproductive and respiratory syndrome virus on lymphoproliferative recall responses of CD8+ T cells.
Bassaganya-Riera J; Thacker BJ; Yu S; Strait E; Wannemuehler MJ; Thacker EL
Viral Immunol; 2004; 17(1):25-37. PubMed ID: 15018660
[TBL] [Abstract][Full Text] [Related]
11. Immune responses and protection by vaccine and various vaccine adjuvant candidates to virulent porcine reproductive and respiratory syndrome virus.
Charerntantanakul W; Platt R; Johnson W; Roof M; Vaughn E; Roth JA
Vet Immunol Immunopathol; 2006 Jan; 109(1-2):99-115. PubMed ID: 16165219
[TBL] [Abstract][Full Text] [Related]
12. A modified-live porcine reproductive and respiratory syndrome virus (PRRSV)-1 vaccine protects late-term pregnancy gilts against heterologous PRRSV-1 but not PRRSV-2 challenge.
Jeong J; Kang I; Kim S; Park SJ; Park KH; Oh T; Yang S; Chae C
Transbound Emerg Dis; 2018 Oct; 65(5):1227-1234. PubMed ID: 29536637
[TBL] [Abstract][Full Text] [Related]
13. Reproductive, productivity, and mortality outcomes in late-gestation gilts and their litters following simulation of inadvertent exposure to a modified-live vaccine strain of porcine reproductive and respiratory syndrome (PRRS) virus.
Schelkopf A; Nerem J; Cowles B; Amodie D; Swalla R; Dee S
Vaccine; 2014 Aug; 32(36):4639-43. PubMed ID: 24975816
[TBL] [Abstract][Full Text] [Related]
14. Cross-protection of a modified-live porcine reproductive and respiratory syndrome virus (PRRSV)-2 vaccine against a heterologous PRRSV-1 challenge in late-term pregnancy gilts.
Jeong J; Park C; Oh T; Park KH; Yang S; Kang I; Park SJ; Chae C
Vet Microbiol; 2018 Sep; 223():119-125. PubMed ID: 30173737
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: Clinical protection and cell-mediated immunity.
Martelli P; Gozio S; Ferrari L; Rosina S; De Angelis E; Quintavalla C; Bottarelli E; Borghetti P
Vaccine; 2009 Jun; 27(28):3788-99. PubMed ID: 19442420
[TBL] [Abstract][Full Text] [Related]
16. Effects of North American porcine reproductive and respiratory syndrome virus (PRRSV)-based modified live vaccines on preimmunized sows artificially inseminated with European PRRSV-spiked semen.
Han K; Seo HW; Oh Y; Kang I; Park C; Chae C
Clin Vaccine Immunol; 2012 Mar; 19(3):319-24. PubMed ID: 22237898
[TBL] [Abstract][Full Text] [Related]
17. Effect of immunologic solutions on sows and gilts on time to stability, and production losses in breeding herds infected with 1-7-4 PRRSv.
Linhares DCL; Betlach C; Morrison RB
Prev Vet Med; 2017 Sep; 144():112-116. PubMed ID: 28716191
[TBL] [Abstract][Full Text] [Related]
18. Vaccination of sows against type 2 Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) before artificial insemination protects against type 2 PRRSV challenge but does not protect against type 1 PRRSV challenge in late gestation.
Han K; Seo HW; Park C; Chae C
Vet Res; 2014 Feb; 45(1):12. PubMed ID: 24484238
[TBL] [Abstract][Full Text] [Related]
19. A comparison of commercial modified-live PRRSV-1 and PRRSV-2 vaccines against a dual heterologous PRRSV-1 and PRRSV-2 challenge in late term pregnancy gilts.
Yang S; Oh T; Cho H; Chae C
Comp Immunol Microbiol Infect Dis; 2020 Apr; 69():101423. PubMed ID: 31972500
[TBL] [Abstract][Full Text] [Related]
20. Long-term administration of a commercial porcine reproductive and respiratory syndrome virus (PRRSV)-inactivated vaccine in PRRSV-endemically infected sows.
Papatsiros VG; Alexopoulos C; Kritas SK; Koptopoulos G; Nauwynck HJ; Pensaert MB; Kyriakis SC
J Vet Med B Infect Dis Vet Public Health; 2006 Aug; 53(6):266-72. PubMed ID: 16907957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
